New ways to treat AIDS with new genetic and cellular methods

2020 May 14 News /BioValleyBIOON / - Hamburg researchers are trying to improve the future use of a new method of gene and cell treatment of AIDS patientsWith the support of Hamburg biotech startups Provirex, they are developing a new method of treatment, the use of "gene scissors" to cut the AIDS pathogen HIV genes from the genome of the infected cell, and destroy the virusThis is the first time makes it possible to remove the virus, rather than as before treatment just shut out the virusThe start-up company will promote the further development of Brec1 technologyMax Planck Innovation is a technology company laid the foundation for innovative HIV gene scissorsSource: https:This concept is based on JoachimHauber //cn.bing.com and his team at the Heinrich - Pater Institute (HPI), Leibniz Experimental VirologyResearch Institute and the Max Planck Institute for molecular cell Biology and genetic and Dresden technical University conductedTogether they developed and optimized "gene scissors": recombinase Brec1This method is currently HPI and Hamburg-Eppendorf (UKE) a medical center in cooperation a clinical trialUnder the leadership of NicolausKroger, it will conduct a preliminary assessment as part ofstem cell therapy involves eight AIDS patients UKEtransplant department of stem cellsGerman Federal Ministry of Education and Research (BMBF), the Hamburg Senate and the Irish Trask Rhone - a subsidiary of Fresenius Foundation (EKFS) for this purpose provided funding and resourcesscientific Senator KatharinaFegebank said: "The Hamburg start-up companies Provirex can make a decisive contribution to the fight against HIV and AIDS, this new treatment could cause permanent patient cells for the first time, in exactly from HIVfreed, it will be a cure medical, social and historical breakthrough in HIV and AIDSthis could become a milestone in the fight against HIVwe are pleased to now have the opportunity to develop new treatments based on our own research in the UKE campus Hamburg methods"
as one of three technology providers, the Max Planck innovative companies with major partners Ascenion company and the transfer of the technical University of Dresden have been authorized Provirex close and constructive cooperationMember of the Max-Planck-Innovation Management Committee UlrichMahr company said: "We are very pleased Provirex will promote an innovative method forclinical trialsHIV treatment for the benefit of affected patients." a (Biovalley Bioon.com) references:NewapproachtocuringHIVusingnovelgeneandcellmethod